Clinical Trial OPEN: Liver-Targeted Insulin More Effective than Insulin?
Trial name: Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects Diabetes type: Type 1 diabetes What the trial is testing: This six-month study will test the safety and efficacy of HDV insulin, a new technology that directs meal-time rapid-acting insulin...
AFREZZA is BACK!
Afrezza is BACK! After Sanofi terminated its marketing partnership with MannKind, MannKind has relaunched its fast-acting inhalable insulin, Afrezza, as reported in DiaTribe.org on 30 August, 2016. I, for one, couldn’t be happier and more relieved. ...
SPOTLIGHT: On The Bonnie Sher Show!
A STAR is BORN! Yup, little ‘ol me! Mr. deMille, I’m ready for my close-up!!! OK, enough! I was honored to be asked to be a T1d Co-Host on The Bonnie Sher Show, broadcast on UBN internet radio/tv, on Thursday, 15 September 2016. Bonnie is a long-time...
WAY OUT THERE: Non-Scientists Try to Break Up Monopoly on Insulin
OK, … this is WAY OUT THERE … or is it? (this is not a recommendation or endorsement) Listen to this podcast from The Pulse, reporting on an Oakland, CA grassroots community lab for biohacking and citizen science. According to their website,...
More Diabetes Blogs